NYLI Global Equity R&D Leaders ETF (WRND) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

NYLI Global Equity R&D Leaders ETF (WRND) operates in the Financial Services sector, specifically the Asset Management - Global industry, with a market capitalization near $10.6M, listed on NASDAQ, carrying a beta of 1.15 to the broader market. The NYLI Global Equity R&D Leaders ETF (WRND) aims to replicate the total return of the NYLI Global Equity R&D Leaders Index, before any deductions for fees or operating expenses. public since 2022-02-08.

Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for WRND as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how max pain is reported and how to read the data →